These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30485769)

  • 1. Mutagenesis in Norovirus in Response to Favipiravir Treatment.
    Ruis C; Brown LK; Roy S; Atkinson C; Williams R; Burns SO; Yara-Romero E; Jacobs M; Goldstein R; Breuer J; Lowe DM
    N Engl J Med; 2018 Nov; 379(22):2173-2176. PubMed ID: 30485769
    [No Abstract]   [Full Text] [Related]  

  • 2. Favipiravir elicits antiviral mutagenesis during virus replication in vivo.
    Arias A; Thorne L; Goodfellow I
    Elife; 2014 Oct; 3():e03679. PubMed ID: 25333492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis.
    Thorne L; Arias A; Goodfellow I
    J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S27-31. PubMed ID: 26744429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.
    Yu P; Wang Y; Li Y; Li Y; Miao Z; Peppelenbosch MP; Pan Q
    Arch Virol; 2020 Nov; 165(11):2605-2613. PubMed ID: 32770483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic norovirus infection and common variable immunodeficiency.
    Woodward J; Gkrania-Klotsas E; Kumararatne D
    Clin Exp Immunol; 2017 Jun; 188(3):363-370. PubMed ID: 27753065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.
    Rocha-Pereira J; Van Dycke J; Neyts J
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1907-11. PubMed ID: 26711754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favipiravir and COVID-19: A Simplified Summary.
    Ghasemnejad-Berenji M; Pashapour S
    Drug Res (Stuttg); 2021 Mar; 71(3):166-170. PubMed ID: 33176367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Favipiravir, a new concept of antiviral drug against influenza viruses].
    Reina J; Reina N
    Rev Esp Quimioter; 2017 Apr; 30(2):79-83. PubMed ID: 28176519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.
    Woodward JM; Gkrania-Klotsas E; Cordero-Ng AY; Aravinthan A; Bandoh BN; Liu H; Davies S; Zhang H; Stevenson P; Curran MD; Kumararatne D
    Am J Gastroenterol; 2015 Feb; 110(2):320-7. PubMed ID: 25623655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norovirus genetic diversity and evolution: implications for antiviral therapy.
    Rocha-Pereira J; Van Dycke J; Neyts J
    Curr Opin Virol; 2016 Oct; 20():92-98. PubMed ID: 27736665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.
    Rocha-Pereira J; Kolawole AO; Verbeken E; Wobus CE; Neyts J
    Antiviral Res; 2016 Aug; 132():76-84. PubMed ID: 27252124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis.
    Escribano-Romero E; Jiménez de Oya N; Domingo E; Saiz JC
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norovirus: targets and tools in antiviral drug discovery.
    Rocha-Pereira J; Neyts J; Jochmans D
    Biochem Pharmacol; 2014 Sep; 91(1):1-11. PubMed ID: 24893351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency.
    van Kampen JJA; Dalm VASH; Fraaij PLA; Oude Munnink BB; Schapendonk CME; Izquierdo-Lara RW; Villabruna N; Ettayebi K; Estes MK; Koopmans MPG; de Graaf M
    J Infect Dis; 2022 Nov; 226(10):1781-1789. PubMed ID: 35255136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of chronic norovirus gastroenteritis with nitazoxanide in a pediatric kidney transplant recipient.
    Haubrich K; Gantt S; Blydt-Hansen T
    Pediatr Transplant; 2018 Jun; 22(4):e13186. PubMed ID: 29635723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favipiravir (T-705) inhibits in vitro norovirus replication.
    Rocha-Pereira J; Jochmans D; Dallmeier K; Leyssen P; Nascimento MS; Neyts J
    Biochem Biophys Res Commun; 2012 Aug; 424(4):777-80. PubMed ID: 22809499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
    Takashita E; Ejima M; Ogawa R; Fujisaki S; Neumann G; Furuta Y; Kawaoka Y; Tashiro M; Odagiri T
    Antiviral Res; 2016 Aug; 132():170-7. PubMed ID: 27321665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
    Yamada K; Noguchi K; Komeno T; Furuta Y; Nishizono A
    J Infect Dis; 2016 Apr; 213(8):1253-61. PubMed ID: 26655300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive characterization of chronic norovirus infection in immunodeficient hosts.
    Brown LK; Ruis C; Clark I; Roy S; Brown JR; Albuquerque AS; Patel SY; Miller J; Karim MY; Dervisevic S; Moore J; Williams CA; Cudini J; Moreira F; Neild P; Seneviratne SL; Workman S; Toumpanakis C; Atkinson C; Burns SO; Breuer J; Lowe DM
    J Allergy Clin Immunol; 2019 Nov; 144(5):1450-1453. PubMed ID: 31415785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.